10-Q: Cytta Corp. Reports Q2 2024 Results with Increased Operating Expenses and Continued Net Losses

Sentiment:

Quarterly Report 20 May 2024 4:48 PM

Cytta Corp.'s Q2 2024 results show a decrease in revenue and an increase in operating expenses, leading to a net loss of $2,047,669 for the six-month period ending March 31, 2024.

Capital raiseThe company intends to fund operations through equity and/or debt financing arrangements.The company has issued $1,537,950 of convertible notes since April 1, 2024.The company may be unable to obtain sufficient additional capital to fund operations and expand its business.

Worse than expectedThe company's revenue decreased significantly compared to the same period last year.Operating expenses increased, leading to a larger net loss.The accumulated deficit has grown substantially, raising concerns about the company's financial stability.

Summary

Cytta Corp. reported its financial results for the quarter and six months ended March 31, 2024.
The company's revenue decreased to $2,411 for the six-month period, down from $13,824 in the same period last year.
Operating expenses increased to $1,896,162 for the six-month period, compared to $1,766,564 in the prior year.
The company reported a net loss of $2,047,669 for the six-month period, compared to a net loss of $1,764,019 in the same period last year.
The company's accumulated deficit has grown to $34,651,149, raising concerns about its ability to continue as a going concern.
Cytta is focusing on developing and commercializing its technologies, including CyttaCOMMS, CyttaCARES, and CyttaCOMP ISTAR.
The company is funding operations through equity and debt financing, which may not be sufficient for future needs.

Sentiment

Score: 3

Explanation: The document reveals significant financial challenges, including decreased revenue, increased losses, and a substantial accumulated deficit. The company's going concern status and material weaknesses in internal controls further contribute to a negative outlook. While there are some positive developments in product development, the overall financial picture is concerning.

Positives

Cytta is actively developing and commercializing its technology, including CyttaCARES and CyttaCOMMS.
The company has secured additional funding through convertible notes after the reporting period.
Cytta has made progress in transitioning from product software development to a full SaaS commercial release.

Negatives

The company experienced a significant decrease in revenue compared to the same period last year.
Operating expenses have increased, contributing to a larger net loss.
The accumulated deficit has grown substantially, raising concerns about the company's financial stability.
The company has a working capital deficiency of $2,072,995.
The company's disclosure controls and procedures were deemed ineffective due to material weaknesses in internal controls.

Risks

The company's ability to continue as a going concern is in doubt due to recurring losses and the need for additional capital.
The company may be unable to obtain sufficient additional capital to fund operations and expand its business.
The company's internal controls over financial reporting have material weaknesses, which could lead to misstatements in financial reports.
The company is reliant on debt and equity financing, which may not be sufficient for future needs.
The company's convertible notes have the potential to dilute existing shareholders.

Future Outlook

The company intends to fund operations through equity and/or debt financing arrangements, which may not be sufficient to fund its capital expenditures, working capital and other cash requirements for the foreseeable future.

Management Comments

Management believes that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made.
Management does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud.

Industry Context

Cytta operates in the technology sector, focusing on video compression and communication solutions. The company's products target markets such as first responders, educational institutions, and military applications. The increased operating expenses reflect the company's efforts to transition from product development to commercialization, which is a common phase for technology startups. The company's reliance on debt and equity financing is also typical for early-stage technology companies.

Comparison to Industry Standards

Cytta's financial performance is weak compared to established technology companies, which typically have higher revenue and lower losses.
The company's reliance on convertible debt is a common practice for early-stage companies, but the high interest rates (18%) are concerning.
The lack of an audit committee and material weaknesses in internal controls are significant issues that need to be addressed to meet industry standards for financial reporting.
The company's stock-based compensation expenses are high, which is not uncommon for startups but needs to be managed carefully.
The company's technology, particularly CyttaCOMP, is positioned to compete with other video compression technologies, but its commercial success is yet to be proven.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Internal Control Weakness	The company does not have an Audit Committee and has not maintained appropriate cash controls.	2024-03-31	This is a material weakness that could lead to misstatements in financial reports.

Related Party Transactions

The company recorded expenses to related parties for management fees, stock-based compensation, and office rent.
As of March 31, 2024, the company owes $680,061 to related parties.

Stakeholder Impact

Shareholders face the risk of further dilution due to the issuance of convertible notes and common stock.
Employees may be impacted by the company's financial instability.
Customers may be affected by the company's ability to deliver products and services.
Creditors face the risk of non-payment due to the company's financial difficulties.

Next Steps

The company needs to secure additional funding to continue operations.
The company needs to improve its internal controls over financial reporting.
The company needs to focus on commercializing its products and generating revenue.
The company needs to manage its operating expenses to reduce losses.

Key Dates

Date	Description
2006-05-30	Cytta Corp. was incorporated.
2020-10-25	Cytta entered a sublease agreement with its CTO.
2022-08-09	Cytta signed an Intellectual Property License Agreement with Reticulate Micro, Inc.
2023-01-10	Cytta entered into an 8%, $40,000 face value unsecured promissory note.
2023-02-01	Cytta entered a Consulting Executive Officer Agreement with a three-year term.
2023-02-10	Cytta issued a convertible promissory note in the principal amount of $50,000.
2023-02-17	Cytta issued a convertible promissory note in the principal amount of $25,000.
2023-02-24	Cytta issued a convertible promissory note in the principal amount of $25,000.
2023-02-28	Cytta issued a convertible promissory note in the principal amount of $10,000.
2023-03-03	Cytta issued a convertible promissory note in the principal amount of $50,000.
2023-05-03	Cytta issued a convertible promissory note in the principal amount of $50,000.
2023-05-15	Mr. Collins cancelled his 1,600,000 shares of Class B common stock in exchange for 200,000 shares of Class A common stock.
2023-06-16	Cytta issued a convertible promissory note in the principal amount of $500,000.
2023-08-02	Cytta issued a convertible promissory note in the principal amount of $500,000 and $5,000.
2023-10-01	The COO was appointed as President.
2023-12-28	Cytta issued a convertible promissory note in the principal amount of $40,000.
2024-01-12	Cytta issued a convertible promissory note in the principal amount of $250,000.
2024-01-18	Cytta issued 5,000,000 shares of common stock for services.
2024-01-12	Cytta issued 2,227,661 shares of common stock for payment of accounts payable and accrued interest.
2024-03-21	Cytta issued a convertible promissory note in the principal amount of $25,000.
2024-03-26	Cytta issued convertible promissory notes in the principal amount of $25,000, $62,500 and $50,000.
2024-03-27	Cytta issued a convertible promissory note in the principal amount of $25,000.
2024-03-28	Cytta issued convertible promissory notes in the principal amount of $25,000 and $30,000.
2024-03-29	Cytta issued a convertible promissory note in the principal amount of $25,000.
2024-03-31	End of the reporting period.
2024-04-01	Cytta recorded the transfer of 3,682 shares of RM stock for accrued interest.
2024-04-01	Cytta entered an Agreement for Board of Advisor Services.
2024-04-23	Cytta entered Agreements for Board of Advisor Services.
2024-05-08	Cytta issued shares of common stock for various agreements and bonuses.
2024-05-14	Cytta settled a $50,000 convertible promissory note by issuing RM stock and common stock.
2024-05-16	Cytta issued shares to consultants.
2024-05-20	Date of report filing.

Keywords

Cytta Corp, Financial Results, Quarterly Report, Net Loss, Operating Expenses, Revenue, Convertible Notes, Stock Issuance, SaaS, CyttaCOMMS, CyttaCARES, Going Concern, Internal Controls

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.